Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria.
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria.
Neuroimage. 2021 Aug 1;236:118039. doi: 10.1016/j.neuroimage.2021.118039. Epub 2021 Apr 20.
Animal studies using selective serotonin reuptake inhibitors (SSRIs) and learning paradigms have demonstrated that serotonin is important for flexibility in executive functions and learning. SSRIs might facilitate relearning through neuroplastic processes and thus exert their clinical effects in psychiatric diseases where cognitive functioning is affected. However, translation of these mechanisms to humans is missing. In this randomized placebo-controlled trial, we assessed functional brain activation during learning and memory retrieval in healthy volunteers performing associative learning tasks aiming to translate facilitated relearning by SSRIs. To this extent, seventy-six participants underwent three MRI scanning sessions: (1) at baseline, (2) after three weeks of daily associative learning and subsequent retrieval (face-matching or Chinese character-noun matching) and (3) after three weeks of relearning under escitalopram (10 mg/day) or placebo. Associative learning and retrieval tasks were performed during each functional MRI (fMRI) session. Statistical modeling was done using a repeated-measures ANOVA, to test for content-by-treatment-by-time interaction effects. During the learning task, a significant substance-by-time interaction was found in the right insula showing a greater deactivation in the SSRI cohort after 21 days of relearning compared to the learning phase. In the retrieval task, there was a significant content-by-time interaction in the left angular gyrus (AG) with an increased activation in face-matching compared to Chinese-character matching for both learning and relearning phases. A further substance-by-time interaction was found in task performance after 21 days of relearning, indicating a greater decrease of performance in the placebo group. Our findings that escitalopram modulate insula activation demonstrates successful translation of relearning as a mechanism of SSRIs in human. Furthermore, we show that the left AG is an active component of correct memory retrieval, which coincides with previous literature. We extend the function of this region by demonstrating its activation is not only stimulus dependent but also time constrained. Finally, we were able to show that escitalopram aids in relearning, irrespective of content.
动物研究使用选择性 5-羟色胺再摄取抑制剂(SSRIs)和学习范式表明,5-羟色胺对于执行功能和学习的灵活性很重要。SSRIs 通过神经可塑性过程促进重新学习,从而在认知功能受到影响的精神疾病中发挥其临床作用。然而,这些机制在人类身上的转化尚不清楚。在这项随机安慰剂对照试验中,我们评估了健康志愿者在执行联想学习任务时学习和记忆检索过程中的大脑功能激活情况,旨在翻译 SSRIs 促进重新学习的机制。为此,76 名参与者接受了三次 MRI 扫描:(1)基线时,(2)在三周的日常联想学习和随后的检索(面孔匹配或汉字-名词匹配)后,以及(3)在三周的依他普仑(10mg/天)或安慰剂重新学习后。在每次功能磁共振成像(fMRI)扫描期间进行联想学习和检索任务。使用重复测量方差分析进行统计建模,以测试内容-治疗-时间的交互效应。在学习任务中,在右侧脑岛发现了显著的物质-时间交互作用,表明在重新学习 21 天后,SSRIs 组的去激活程度大于学习阶段。在检索任务中,在左侧角回(AG)中发现了显著的内容-时间交互作用,与学习和重新学习阶段的汉字匹配相比,面孔匹配的激活增加。在重新学习 21 天后的任务表现中发现了进一步的物质-时间交互作用,表明安慰剂组的表现下降更大。我们发现依他普仑调节脑岛的激活,证明了重新学习作为 SSRIs 机制在人类中的成功转化。此外,我们表明左 AG 是正确记忆检索的一个活跃成分,这与以前的文献一致。我们通过证明其激活不仅依赖于刺激,而且还受时间限制,扩展了该区域的功能。最后,我们能够表明,依他普仑有助于重新学习,而与内容无关。